Advertisement

Picture [iito] No Tracking 650x80px
Document › Details

Boehringer Ingelheim. (5/14/15). "Press Release: Boehringer Ingelheim Showcases Expanding Presence in Lung Cancer at ASCO 2015 with New Data including Presentation of Afatinib Overall Survival Results for Squamous Cell Carcinoma of the Lung". Ingelheim.

Region Region Chicago, IL
  Country United States (USA)
Organisations Organisation Boehringer Ingelheim GmbH
  Group Boehringer Ingelheim (Group)
  Organisation 2 American Society of Clinical Oncology (ASCO)
Products Product afatinib
  Product 2 nintedanib
Person Person Malin, Reinhard (Boehringer Ingelheim 201505 Director Media + PR)
     


   
Record changed: 2017-04-02

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Boehringer Ingelheim (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81




» top